Nerbio's iTOF is the world's first FDA-cleared app-controlled neuromuscular blockade (NMB) monitoring device.
Nerbio Medical Software Platforms Inc. has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
Nerbio Medical Software Platforms Inc. is headquartered in San Jose, United States.
Nerbio's iTOF is the world's first FDA-cleared app-controlled neuromuscular blockade (NMB) monitoring device.
Nerbio Medical Software Platforms Inc. is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nerbio Medical Software Platforms Inc. — Funding & Investors." VCBacked, May 4, 2024, https://www.vcbacked.co/company/nerbio-medical-software-platforms-inc. Accessed November 16, 2026.
VCBacked. (2024). Nerbio Medical Software Platforms Inc. — Funding & Investors. Retrieved November 16, 2026, from https://www.vcbacked.co/company/nerbio-medical-software-platforms-inc
{{cite web |title=Nerbio Medical Software Platforms Inc. — Funding & Investors |url=https://www.vcbacked.co/company/nerbio-medical-software-platforms-inc |website=VCBacked |access-date=November 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Nerbio Medical Software Platforms Inc.? Request a listing update